OZANIMOD (has an active metabolite) | OZANIMOD | ATC L04AA38
IMMUNOMODULATING SPHINGOSINE 1- PHOSPHATE RECEPTOR (SIP) MODULATOR TREATMENT OF RELAPSING FORMS OF MULTIPLE SCLEROSIS (MS) | ORAL | Cmax 0.6 NANOMOLAR Tmax 7 HOUR VD 5590 LITER PPB 98.2 PERCENT Cl 192 LITER / HOUR HT 21 HOUR SOLUBILITY FREELY SOLUBLE IN WATER | SPHINGOSINE 1- PHOSPHATE RECEPTORS S1P 1 AND 5 | Sphingosine 1-phosphate receptor 1 agonist P21453 S1PR1_HUMAN | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |